Sarilumab

Category: Arthritis



Sarilumab Overview

Sarilumab (trade name Kevzara) is a human monoclonal antibody against the interleukin-6 receptor.[1] Regeneron and Sanofi developed the drug for the treatment of rheumatoid arthritis (RA), for which it received US FDA approval on 22 May 2017 and European Medicines Agency approval on 23 June 2017.[2] Development in ankylosing spondylitis has been suspended after the drug failed to show clinical benefit over methotrexate in a phase II trial.[3] ...

Read more Sarilumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sarilumab

Recent Sarilumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sarilumab
  • Injection: 150mg/1.14ml, 200mg/1.14ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Sarilumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA